Hazards of Hormonal Eczema Creams for Infants
Mar 31, 2022
Source: Cainiu Health
Dr. Ma Yan
Introduction
Long-term use of corticosteroid-based eczema ointments in infants may cause skin darkening or thinning. Prolonged application of such ointments to treat infantile eczema can lead to skin hyperpigmentation or atrophy, and may also result in corticosteroid dependence. Once treatment is discontinued, the condition may recur or worsen.
When discussing the treatment of infantile eczema, topical corticosteroid ointments inevitably come to mind. Indeed, topical corticosteroids are considered first-line therapy for eczema. So, what are the potential risks associated with using corticosteroid ointments for infants? Below, we address this question.
Potential Risks of Corticosteroid Ointments in Infants
Prolonged use of corticosteroid ointments in infants may lead to skin hyperpigmentation (darkening) or skin atrophy (thinning).
If infants with eczema use corticosteroid ointments over an extended period, their skin may darken or thin, and they may even develop corticosteroid dependence. Discontinuation of the medication may then trigger disease recurrence or exacerbation. For mild cases of infantile eczema, milder anti-eczema agents—such as calamine lotion or zinc oxide ointment—may be appropriate alternatives.
Eczema is a common, chronic, inflammatory, and pruritic (itchy) skin disorder. It affects individuals across all age groups and genders, and is highly prone to recurrence, often requiring long-term management. Eczema may arise from various factors, including chronic infection, immunosuppression, genetic predisposition, poor dietary habits, and psychological stress. Clinical manifestations include skin edema, erythema (redness), papules, pruritus (itching), scaling, and swelling.
As a chronic condition, eczema is difficult to cure completely; therefore, appropriate daily prevention is essential to alleviate symptoms and reduce recurrence. During active disease, patients should avoid scratching affected areas.
The above outlines the potential risks associated with corticosteroid ointments in infants. We hope this information is helpful to you.
